Aparna Krishnan

988 total citations
17 papers, 797 citations indexed

About

Aparna Krishnan is a scholar working on Epidemiology, Immunology and Hematology. According to data from OpenAlex, Aparna Krishnan has authored 17 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 4 papers in Immunology and 3 papers in Hematology. Recurrent topics in Aparna Krishnan's work include Herpesvirus Infections and Treatments (8 papers), Cytomegalovirus and herpesvirus research (8 papers) and Multiple Myeloma Research and Treatments (3 papers). Aparna Krishnan is often cited by papers focused on Herpesvirus Infections and Treatments (8 papers), Cytomegalovirus and herpesvirus research (8 papers) and Multiple Myeloma Research and Treatments (3 papers). Aparna Krishnan collaborates with scholars based in United States, France and Netherlands. Aparna Krishnan's co-authors include Khaliquz Zaman, Gabriel Fernandes, Richard Lawrence, Dongxu Sun, Arunabh Bhattacharya, Bharath Chandrasekaran, Jackson T. Gandour, Don J. Diamond, Corinna La Rosa and Ajit P. Limaye and has published in prestigious journals such as Blood, The Journal of Infectious Diseases and Journal of Bone and Mineral Research.

In The Last Decade

Aparna Krishnan

17 papers receiving 773 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aparna Krishnan United States 13 282 165 152 119 116 17 797
Martin Lopez Canada 13 177 0.6× 83 0.5× 160 1.1× 19 0.2× 170 1.5× 17 632
Alok Sharma India 9 196 0.7× 93 0.6× 50 0.3× 26 0.2× 53 0.5× 20 689
Vanessa S. Mattevi Brazil 18 158 0.6× 104 0.6× 129 0.8× 14 0.1× 110 0.9× 47 832
Montserrat Vayreda Spain 7 247 0.9× 34 0.2× 63 0.4× 9 0.1× 70 0.6× 9 618
Anna Lisowska Poland 20 157 0.6× 17 0.1× 107 0.7× 43 0.4× 272 2.3× 107 1.1k
Ko‐Huang Lue Taiwan 18 76 0.3× 20 0.1× 101 0.7× 16 0.1× 105 0.9× 47 896
Leandro P. Araújo Brazil 15 81 0.3× 38 0.2× 240 1.6× 16 0.1× 408 3.5× 20 902
Chunlin Wang China 16 204 0.7× 16 0.1× 36 0.2× 56 0.5× 205 1.8× 62 845
Maya D. Srivastava United States 14 79 0.3× 60 0.4× 221 1.5× 25 0.2× 125 1.1× 32 683

Countries citing papers authored by Aparna Krishnan

Since Specialization
Citations

This map shows the geographic impact of Aparna Krishnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aparna Krishnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aparna Krishnan more than expected).

Fields of papers citing papers by Aparna Krishnan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aparna Krishnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aparna Krishnan. The network helps show where Aparna Krishnan may publish in the future.

Co-authorship network of co-authors of Aparna Krishnan

This figure shows the co-authorship network connecting the top 25 collaborators of Aparna Krishnan. A scholar is included among the top collaborators of Aparna Krishnan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aparna Krishnan. Aparna Krishnan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Rodríguez‐Otero, Paula, Anita D’Souza, Donna Reece, et al.. (2022). S188: TECLISTAMAB IN COMBINATION WITH DARATUMUMAB, A NOVEL, IMMUNOTHERAPY-BASED APPROACH FOR THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED PHASE 1B RESULTS. HemaSphere. 6. 89–90. 12 indexed citations
3.
4.
Lacey, Simon F., Corinna La Rosa, Teodora Kaltcheva, et al.. (2011). Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic mice. Blood. 118(8). 2159–2169. 12 indexed citations
5.
Rosa, Corinna La, Ajit P. Limaye, Aparna Krishnan, et al.. (2011). Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipients. Transplant International. 24(9). 920–931. 23 indexed citations
6.
Krishnan, Aparna, Wendi Zhou, Simon F. Lacey, et al.. (2010). Programmed death-1 receptor and interleukin-10 in liver transplant recipients at high risk for late cytomegalovirus disease. Transplant Infectious Disease. 12(4). 363–370. 25 indexed citations
7.
Chandrasekaran, Bharath, Aparna Krishnan, & Jackson T. Gandour. (2008). Relative influence of musical and linguistic experience on early cortical processing of pitch contours. Brain and Language. 108(1). 1–9. 129 indexed citations
8.
Krishnan, Aparna, et al.. (2008). A novel approach to evaluate the immunogenicity of viral antigens of clinical importance in HLA transgenic murine models. Immunology Letters. 120(1-2). 108–116. 8 indexed citations
9.
Rosa, Corinna La, Ajit P. Limaye, Aparna Krishnan, Jeff Longmate, & Don J. Diamond. (2007). Longitudinal Assessment of Cytomegalovirus (CMV)–Specific Immune Responses in Liver Transplant Recipients at High Risk for Late CMV Disease. The Journal of Infectious Diseases. 195(5). 633–644. 81 indexed citations
10.
Rosa, Corinna La, Aparna Krishnan, Jeff Longmate, et al.. (2007). Programmed Death–1 Expression in Liver Transplant Recipients as a Prognostic Indicator of Cytomegalovirus Disease. The Journal of Infectious Diseases. 197(1). 25–33. 53 indexed citations
11.
Lacey, Simon F., Corinna La Rosa, Wendy Zhou, et al.. (2006). Functional Comparison of T Cells Recognizing Cytomegalovirus pp65 and Intermediate‐Early Antigen Polypeptides in Hematopoietic Stem‐Cell Transplant and Solid Organ Transplant Recipients. The Journal of Infectious Diseases. 194(10). 1410–1421. 42 indexed citations
12.
Rosa, Corinna La, Zhongde Wang, Simon F. Lacey, et al.. (2006). In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia Ankara. Experimental Hematology. 34(4). 497–507. 19 indexed citations
13.
Wang, Zhongde, Corinna La Rosa, Zhongqi Li, et al.. (2006). Vaccine properties of a novel marker gene-free recombinant modified vaccinia Ankara expressing immunodominant CMV antigens pp65 and IE1. Vaccine. 25(6). 1132–1141. 26 indexed citations
14.
Krishnan, Aparna, et al.. (2005). Field validation of sensitivity and specificity of rapid test for detection of Brugia malayi infection. Tropical Medicine & International Health. 10(1). 99–104. 18 indexed citations
15.
Sun, Dongxu, Aparna Krishnan, Jianrong Su, et al.. (2004). Regulation of immune function by calorie restriction and cyclophosphamide treatment in lupus-prone NZB/NZW F1 mice. Cellular Immunology. 228(1). 54–65. 35 indexed citations
16.
Bhattacharya, Arunabh, Richard Lawrence, Aparna Krishnan, et al.. (2003). Effect of Dietary n-3 and n-6 Oils with and without Food Restriction on Activity of Antioxidant Enzymes and Lipid Peroxidation in Livers of Cyclophosphamide Treated Autoimmune-Prone NZB/W Female Mice. Journal of the American College of Nutrition. 22(5). 388–399. 79 indexed citations
17.
Sun, Dongxu, Aparna Krishnan, Khaliquz Zaman, et al.. (2003). Dietary n-3 Fatty Acids Decrease Osteoclastogenesis and Loss of Bone Mass in Ovariectomized Mice. Journal of Bone and Mineral Research. 18(7). 1206–1216. 232 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin Lopez Breakdown of academic impact, for papers by Alok Sharma Breakdown of academic impact, for papers by Vanessa S. Mattevi Breakdown of academic impact, for papers by Montserrat Vayreda Breakdown of academic impact, for papers by Anna Lisowska Breakdown of academic impact, for papers by Ko‐Huang Lue Breakdown of academic impact, for papers by Leandro P. Araújo Breakdown of academic impact, for papers by Chunlin Wang Breakdown of academic impact, for papers by Maya D. Srivastava
Rankless by CCL
2026